Joshua Silverman's Net Worth

$1.76 Million

Estimate Recalculated Apr 10, 2024 03:10PM EST

Who is Joshua Silverman?

Joshua Silverman has an estimated net worth of $1.76 Million. This is based on reported shares across multiple companies, which include Vringo Inc, Petros Pharmaceuticals, Inc., MyMD Pharmaceuticals, Inc., Protagenic Therapeutics, Inc.\new, Synaptogenix, Inc., MGT CAPITAL INVESTMENTS INC, AYRO, Inc., Neurotrope, Inc., TAPIMMUNE INC., PharmaCyte Biotech, Inc., ALANCO TECHNOLOGIES INC, NATIONAL HOLDINGS CORP, 24HOLDINGS INC, and FEMASYS INC.

SEC CIK

Joshua Silverman's CIK is 0001524858

Past Insider Trading and Trends

2020 was Joshua Silverman's most active year for acquiring shares with 21 total transactions. Joshua Silverman's most active month to acquire stocks was the month of January. 2011 was Joshua Silverman's most active year for disposing of shares, totalling 11 transactions. Joshua Silverman's most active month to dispose stocks was the month of November. 2016 saw Joshua Silverman paying a total of $1,402,799.75 for 5,048,590 shares, this is the most they've acquired in one year. In 2021 Joshua Silverman cashed out on 186,833 shares for a total of $391,012.46, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Vringo Inc (XWEL) Snapshot price: $1.63

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-1.01%
-9.00K
$1.16
-$10,440.90
884.8K
Dec 21
Form 4
-0.82%
-7.40K
$1.11
-$8,220.68
893.8K
Dec 19 - Dec 20
Form 4
-0.20%
-1.80K
$1.08
-$1,944.00
901.2K
Dec 15 - Dec 16
Form 4
-1.71%
-15.70K
$1.15
-$18,006.67
903K
Dec 13 - Dec 14
Form 4
-0.31%
-2.90K
$1.21
-$3,511.00
918.7K
Dec 8 - Dec 12
Form 4
-0.54%
-5.00K
$1.51
-$7,550.00
921.6K
Oct 26
Form 3
—
0
—
—
0
No matching records found

Petros Pharmaceuticals, Inc. (PTPI) Snapshot price: $1.14

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 21
Form 4
+148.88%
6.72K
—
—
11.24K
Apr 26
Form 4
—
0
—
—
0
Apr 10
Form 4
+125.75%
2.52K
—
—
4.51K
Jan 20
Form 4
—
0
—
—
0
Apr 7
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Apr 8
Form 4
∞
20K
—
—
20K
Dec 1
Form 3
—
0
—
—
0
No matching records found

MyMD Pharmaceuticals, Inc. (MYMD) Snapshot price: $0.138

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 7
Form 4
+20.33%
15K
$6.89
$103,357.66
88.78K
Nov 24 - Nov 26
Form 4
—
0
—
—
0
Oct 14
Form 4
+63.49%
71.17K
$4.94
-$189,325.50
183.28K
Apr 16
Form 4
—
0
—
—
0
Sep 11
Form 4
∞
5.2K
—
—
5.2K
Jan 1
Form 4
—
0
—
—
0
Mar 29
Form 3
—
0
—
—
0
No matching records found

Protagenic Therapeutics, Inc.\new (PTIX) Snapshot price: $0.8312

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
—
—
0
Oct 16
Form 4
∞
45K
$1.25
$56,250.00
45K
Jun 17
Form 3
—
0
—
—
0
No matching records found

Synaptogenix, Inc. (SNPX) Snapshot price: $0.2009

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 8
Form 4
—
0
—
—
0
Mar 29
Form 4
-33.21%
-19.01K
$1.17
-$22,280.16
38.24K
Scheduled
Dec 16
Form 4/A
+281.67%
42.25K
—
—
57.25K
Jul 13
Form 4/A
—
0
—
—
0
Nov 15
Form 4
—
0
—
—
0
Nov 15
Form 4/A
—
0
—
—
0
Apr 5
Form 4
—
0
—
—
0
Apr 5
Form 4
+600.00%
90K
—
—
105K
Jul 13
Form 4
+200.00%
10K
$8.30
$83,000.00
15K
Jun 14
Form 3
—
0
—
—
0
No matching records found